[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341999-105":59,"doc-detail-341999-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cutaneous-basal-cell-carcinoma-in-situ-a-review-of-the-world-literature","Cutaneous Basal Cell Carcinoma In Situ - A Review of the World Literature","","Cutaneous basal cell carcinoma (BCC) in situ represents a recently recognized skin neoplasm subtype in which abnormal cells remain confined to the epidermis. Formerly labeled as superficial BCC, this entity is reviewed through world literature reports describing 10 cutaneous BCCs in situ across nine patients. The neoplasm often appears as an asymptomatic red plaque, with characteristic epidermal basal-layer tumor cell patterns and contiguous extension into the dermis. Genomic work in one individual highlights PTCH1 alterations while differing mutational burden and PD-L1/PD-L2 amplification between in situ and metastatic lesions, suggesting distinct cellular clones.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cutaneous-basal-cell-carcinoma-in-situ-a-review-of-the-world-literature/341999/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cutaneous-basal-cell-carcinoma-in-situ-a-review-of-the-world-literature/341999.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What distinguishes cutaneous basal cell carcinoma in situ from invasive BCC?","Question",{"text":112,"@type":113},"BCC in situ is defined by neoplastic cells restricted to the epidermis, with possible contiguous extension into the dermis. Invasive cancer involves independently present neoplastic cells in the dermis in a non-contiguous manner.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the review describe the typical clinical presentation of BCC in situ?",{"text":117,"@type":113},"BCC in situ typically presents as an asymptomatic red plaque on areas such as the abdomen, upper extremity, back, and chest.",{"name":119,"@type":110,"acceptedAnswer":120},"What genomic findings are highlighted in the review regarding PTCH1 and tumor evolution?",{"text":121,"@type":113},"PTCH1 gene aberrations are observed, and comparison between an in situ lesion and a metastatic BCC shows differences in tumor mutational burden and absence of PD-L1/PD-L2 amplification in the in situ carcinoma, supporting derivation from different cellular clones.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341999,1790587888,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Review began 09/06/2024  \nReview ended 09/13/2024  \nPublished 09/19/2024  \n© Copyright 2024  \nCohen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0. , which permits unrestricted use , distribution , and reproduction in any medium , provided the original author and source are credited.  \nDOI: 10.7759/cureus.69691  \nOpen Access Review Article  \nCutaneous Basal Cell Carcinoma In Situ: A Review of the World Literature  \nPhilip R. Cohen 1, 2, 3 , Razelle Kurzrock 4, 5, 6  \n1. Dermatology, University of California, Davis Medical Center, Sacramento, USA 2. Dermatology, Touro University California College of Osteopathic Medicine, Vallejo, USA 3. Maples Center for Forensic Medicine, University of Florida College of Medicine-Gainesville, Gainesville, USA 4. Medicine, Medical College of Wisconsin Cancer Center and Genome Sciences and Precision Medicine Center, Milwaukee, USA 5. Oncology, WIN Consortium, Villejuif, FRA 6. Oncology, University of Nebraska Medical Center, Omaha, USA  \nCorresponding author: Philip R. Cohen, [mitehead@gmail.com](mitehead@gmail.com)  \nAbstract  \nCutaneous basal cell carcinoma (BCC) in situ is a recently recognized subtype of the skin neoplasm in which the abnormal cells are confined to the epidermis. BCC in situ of the skin was previously referred to as a superficial BCC. A review of the world literature has revealed 10 cutaneous BCCs in situ that have been described in nine patients but likely reflect a more general phenomenon. The neoplasm typically presents asan asymptomatic red plaque on the abdomen, upper extremity, back, and chest. Pathologic changes frequently show confluent tumor cells along the epidermal basal layer or superficial aggregates of neoplastic cells that are contiguous with the epidermis and extend into the dermis. Genomic evaluation has been performed in neoplasms from one individual with cutaneous BCC in situ and metastatic BCC; like other variants of BCC, an aberration of the PTCH1 gene was observed. In contrast to his liver metastasis, the in situ carcinoma had a lower tumor mutational burden, lacked programmed death-ligand 1 (PD-L1) and programmed death-ligand 2 (PD-L2) amplification and had a distinct PTCH1 mutation, suggesting that the in situ BCC of his skin and the metastatic BCC of his liver were derived from different clones of cells.  \nCategories: Family/General Practice, Internal Medicine, Dermatology  \nKeywords: skin, molecular, in situ, invasive, fibroepithelioma, cutaneous, cell, carcinoma, cancer, basal  \nIntroduction And Background  \nBasal cell carcinoma (BCC) is the most common skin cancer worldwide. BCC has been classified as a tumor with either a low risk of recurrence or metastasis (including those tumors with nonaggressive pathologic features, such as infundibulocystic with adnexal differentiation, fibroepithelial, nodular, pigmented, and superficial) or a higher risk of recurrence and metastasis (which include those tumors with an aggressive histopathologic subtype such as infiltrative, micronodular, morpheaform, and sclerosing) . Risk factors for the development of BCC include exposure to ultraviolet radiation, a family history of BCC, and inherited or de novo mutations of the patched tumor-suppressor genes 1 and 2 (PTCH1 and PTCH2) [1-8].  \nMelanoma and non-melanoma skin cancers (including squamous cell carcinoma and Merkel cell carcinoma) have invasive subtypes and in situ neoplasms [9-15]. Recently, in 2022, an in situ subtype of BCC was  \ndescribed [16]. Previously, these variants of BCC had been referred to as either a superficial BCC or afibroepithelioma of the Pinkus type of BCC [1-8]. In summary, similar to other cutaneous neoplasms such assquamous cell carcinoma and melanoma, BCC also has an in situ subtype [16-21] . The nomenclature used by clinicians is of paramount importance. It enables healthcare professionals to efficiently communicate about their patients. The appropriate design","cbCaisIAqLfmnmma","https://ap.wps.com/l/cbCaisIAqLfmnmma","pdf",2521733,14,"English","# Introduction And Background\n## In situ versus invasive definitions\n## Prior misclassification of BCC variants","[{\"question\":\"What distinguishes cutaneous basal cell carcinoma in situ from invasive BCC?\",\"answer\":\"BCC in situ is defined by neoplastic cells restricted to the epidermis, with possible contiguous extension into the dermis. Invasive cancer involves independently present neoplastic cells in the dermis in a non-contiguous manner.\"},{\"question\":\"How does the review describe the typical clinical presentation of BCC in situ?\",\"answer\":\"BCC in situ typically presents as an asymptomatic red plaque on areas such as the abdomen, upper extremity, back, and chest.\"},{\"question\":\"What genomic findings are highlighted in the review regarding PTCH1 and tumor evolution?\",\"answer\":\"PTCH1 gene aberrations are observed, and comparison between an in situ lesion and a metastatic BCC shows differences in tumor mutational burden and absence of PD-L1/PD-L2 amplification in the in situ carcinoma, supporting derivation from different cellular clones.\"}]","Cutaneous Basal Cell Carcinoma In Situ - A Review of the World Literature | PDF",1790044702,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0bb4e1558713b4370ef72cbf5ef397b8.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f6cc1b64690fdb95c73b4150a3903513.webp",982,1389,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5ba3375d12f9c5e719265232f4421591.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e52e793dfb3db589aea0e998398ada05.webp",980,1386]